Newsmakers

Phoenix Motor (NASDAQ: PEV) Reports Record $9.4 Million Revenue and $14.8 Million Net Income for First Quarter of 2024

ANAHEIM, CA  / October 3, 2024 / Phoenix Motor Inc. (NASDAQ:PEV), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today reported financial and operational results for the first quarter […]

Newsmakers

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

New patent expected to provide market exclusivity into 2036 Zembrace® SymTouch® (sumatriptan succinate injection) 10mg is indicated for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 27, 2024  — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) […]

Newsmakers

iQIYI (NASDAQ: IQ)Unveils Over 300 New Titles at the 2024 iJOY Conference, Adding Focus on Short Dramas to Accelerate Growth

C-Dramas Become Leading Choice in Southeast Asia BEIJING, Sept. 26, 2024 / — QIYI (NASDAQ: IQ), China’s leading online entertainment platform, announced the upcoming release of over 300 new titles across diverse genres over the next year, at […]

Newsmakers

(CSE: NEWS) (OTC: REGRF) WatchReporter.com Beta Release Website Launches Serving Global Watch Enthusiast Market

TORONTO, ON  / September 25, 2024 / New World Solutions Inc. (CSE:NEWS)(OTC PINK:REGRF)(FSE:RT5) (“New World” or the “Company”) announces that its majority-owned dialMKT Corp.(“dialMKT“) subsidiary has launched an updated version of its website at www.WatchReporter.com. The site is an […]

Newsmakers

Plug (NASDAQ: PLUG) Contracts with bp and Iberdrola Joint Venture to Supply 25 MW of PEM Electrolyzers for bp’s Castellón Refinery Project in Valencia, Spain

LATHAM, N.Y., Sept. 18, 2024  — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has secured an order for 25 megawatts (MW) of proton exchange membrane […]

Newsmakers

New World Solutions (CSE: NEWS) Enters $31 Billion Global Watch Market With Acquisition of Majority Stake in dialMKT

TORONTO, ON  / September 18, 2024 / New World Solutions Inc. (CSE:NEWS)(OTC: REGRF)(FSE:RT5) (“New World” or the “Company”) recently announced its acquisition of a majority 51% stake in dialMKT Corp.(“dialMKT“) positions the company to participate in the […]

Newsmakers

FuelCell Energy (NASDAQ: FCEL) Announces Major Clean Fuel Fund Support for eFuel Projects in Canada

Company’s solid oxide electrolysis technology playing central role DANBURY, Conn., Aug. 22, 2024  — FuelCell Energy, Inc., (Nasdaq: FCEL), a global leader in sustainable energy technologies for the delivery of energy and emissions management, announced […]

Newsmakers

Richtech Robotics Celebrates Completion of Installation of ADAM at Ghost Kitchens inside Dawsonville, GA Walmart

LAS VEGAS, July 22, 2024  — Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics”), a Nevada company and a provider of AI-driven service robots, proudly announces the installation of its advanced robotic beverage system, ADAM, at […]

No Picture
Newsmakers

MIRA Pharmaceuticals (NASDAQ: MIRA) Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine’s Drug Resistance

New findings highlight potential advantages of MIRA’s novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL / July 22, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a leading pre-clinical-stage pharmaceutical company, […]

Newsmakers

Biodexa (NASDAQ: BDRX)Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract – Now 12-Month Data

CARDIFF, UK July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is making good progress with eRapa™, […]

Newsmakers

Kazia Therapeutics (NASDAQ: KZIA) Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma

GBM AGILE trial data shows clinically meaningful improvement in a prespecified secondary analysis for overall survival in paxalisib-treated, newly diagnosed unmethylated patients with glioblastoma SYDNEY, July 10, 2024  — Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused […]